JPS604195A - Threitol derivative - Google Patents

Threitol derivative

Info

Publication number
JPS604195A
JPS604195A JP11252683A JP11252683A JPS604195A JP S604195 A JPS604195 A JP S604195A JP 11252683 A JP11252683 A JP 11252683A JP 11252683 A JP11252683 A JP 11252683A JP S604195 A JPS604195 A JP S604195A
Authority
JP
Japan
Prior art keywords
compound
formula
threitol
room temperature
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11252683A
Other languages
Japanese (ja)
Inventor
Masaji Ono
大野雅二
Kagari Fujita
藤田かがり
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Soda Co Ltd
Original Assignee
Nippon Soda Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Soda Co Ltd filed Critical Nippon Soda Co Ltd
Priority to JP11252683A priority Critical patent/JPS604195A/en
Publication of JPS604195A publication Critical patent/JPS604195A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:The compound of formula I (R is 16-18C straight-chain alkyl). EXAMPLE:1-0-Hexadecyl-2,3-di-0-acetyl-D-threitol-4-phosphorylcholine. USE:Hypotensor, blood platelet coagulant, and their intermediate. PREPARATION:The compound of formula I can be prepared by (1) reducing the compound of formula II with palladium black usually in glacial acetic acid at room temperature for 1-10hr to obtain a dihydroxylated compound, and (2) acetylating the product with e.g. acetic anhydride usually in an organic solvent, if necessary in the presence of a base (e.g. pyridine, triethylamine, etc.).

Description

【発明の詳細な説明】 本発明は新規な化合物及びその製造方法に関し、詳しく
は一般式 (式中、Rは016 またはC18の直鎖のアルギル基
を示す。)で表わされる化合物及びその製造方法である
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel compound and a method for producing the same, specifically a compound represented by the general formula (wherein R represents a 016 or C18 linear argyl group) and a method for producing the same. It is.

本発明化合物は血圧降下作用及び血小板凝集活性を有し
、医薬又はその中間体として有用である。
The compounds of the present invention have antihypertensive effects and platelet aggregation activity, and are useful as pharmaceuticals or intermediates thereof.

最近、血圧降下作用を有する化合物として〜 1−O−
アルキル−2−アセチル−・8n−グリセロール−3−
フオスホリルコリン(PAF )の構造が明らかになっ
たが、本発明者等はとのPAFに着目し、さらに研究を
重ねた結果、一般式[1)で表わされる化合物がPAF
と同様の活性を有することを見い出し、本発明を完成し
た。
Recently, ~1-O-
Alkyl-2-acetyl-・8n-glycerol-3-
The structure of phosphorylcholine (PAF) has been clarified, and the present inventors focused on PAF, and as a result of further research, the compound represented by the general formula [1] was found to be PAF.
The present invention has been completed based on the discovery that it has the same activity as .

本発明化合物を製造するにあたっては、一般式(式中R
は前記と同一の、意味を示す。)で表わされる化合物を
還元し、ジヒドロキシ体とし、次いで有機溶媒中必要に
よシ塩基の存在下でアセチル化することによシ製造され
る。
In producing the compound of the present invention, the general formula (in the formula R
indicates the same meaning as above. ) is reduced to form a dihydroxy compound, and then acetylated in an organic solvent in the presence of a dibase as necessary.

還元は通常氷酢酸中ノ4ラジウム黒を用い室温で1時間
から10時間行なわれる。触媒をp別後、P液を濃縮し
、ジヒドロキシ体を得る。
Reduction is usually carried out using 4 radium black in glacial acetic acid at room temperature for 1 to 10 hours. After separating the catalyst from P, the P solution is concentrated to obtain a dihydroxy compound.

アセチル化剤としては通常無水酢酸が使用される。Acetic anhydride is usually used as the acetylating agent.

塩基としてはピリジン、トリエチルアミン等通常の塩基
が使用される。有機溶媒としてはクロロホルム等が使用
されるが、用いるアセチル化剤または塩基をそのまま溶
媒として使用することもできる。
As the base, common bases such as pyridine and triethylamine are used. Chloroform and the like are used as the organic solvent, but the acetylating agent or base used can also be used as is as a solvent.

反応は室温から用いる溶媒の沸点まで、加分から数時間
性なわれる。
The reaction is allowed to proceed from room temperature to the boiling point of the solvent used for several hours after addition.

反応終了後、溶媒を留去し、カラムクロマトグラフィー
で精製して目的化合物を得る。
After the reaction is completed, the solvent is distilled off and purified by column chromatography to obtain the target compound.

一般式〔■〕で表わされる化合物は例えば下記反応式に
従って製造される。
The compound represented by the general formula [■] is produced, for example, according to the following reaction formula.

次に実施例を挙げ本発明を更に詳細に説明する。Next, the present invention will be explained in more detail with reference to Examples.

参考例1 2.3−0−ベンジリデン−D−スレイトールの製造: アルゴン気流下、−(資)℃でリチウムアルミニウムハ
イドライド40mgの乾燥ジエチルエーテル懸濁液に2
.3−0−ベンジリデンジメチル−D−11ルトレイト
2311qヲジエチルエーテル2−に溶解したものを1
0分間で滴下する。そのまま室温まで昇温し、2時間攪
拌後、飽和硫酸ナトリウム水溶液0.22+++j、無
水炭酸カリウム5qを加えさらに攪拌する。不溶物を戸
別後水洗し、無水硫酸マグネシウムで乾燥後、溶媒を留
去する。カラムクロマトグラフィーで精製して目的物1
35■を得る。
Reference Example 1 Production of 2.3-0-benzylidene-D-threitol: Under an argon stream, 2.0% was added to a suspension of 40 mg of lithium aluminum hydride in dry diethyl ether at -(capital)°C.
.. 3-0-benzylidene dimethyl-D-11 lutorate 2311qwo dissolved in diethyl ether 2-
Drop in 0 minutes. The temperature was raised to room temperature, and after stirring for 2 hours, 0.22++j of a saturated aqueous sodium sulfate solution and 5q of anhydrous potassium carbonate were added, followed by further stirring. After washing the insoluble matter with water, drying with anhydrous magnesium sulfate, the solvent is distilled off. Purify by column chromatography to obtain target product 1
Get 35 ■.

収率 74% 旋光度 〔α〕+9.19 (0= 4
.86 。
Yield 74% Optical rotation [α] + 9.19 (0 = 4
.. 86.

0HsOH) 参考例2 1−〇−ヘキサデシルー2.3−0−ベンジリデン−D
−スレイトールの製造: 2.3−0−ベンジリデン−D−スレイトール257■
をDMF 5 mgに溶解し、攪拌下、−加℃で水素化
カリウムの22%鉱油懸濁液0.33−を加え15分間
攪拌する。さらにメタンスルホン酸ヘキサデシへキサン
10−、エタノール10 tnt、水2−を加え、未反
応の水素化カリウム等を分解した後、減圧濃βする。カ
ラムクロマトグラフィーで精製して目−物を得る。 収
率 75チ なおこの生成物はベンジリデンの炭素に関するジアステ
レオマー1:1の混合物(高Rf成分m、:9.41〜
44℃、低Rf成分m、p、 53〜55℃)であるが
以後の反応には分離する必要はない。
0HsOH) Reference example 2 1-〇-hexadecyl-2.3-0-benzylidene-D
-Production of threitol: 2.3-0-benzylidene-D-threitol 257■
was dissolved in 5 mg of DMF, and while stirring, 0.33 cm of a 22% suspension of potassium hydride in mineral oil was added at -°C, and the mixture was stirred for 15 minutes. Furthermore, 10 tons of methanesulfonic acid hexadecyhexane, 10 tons of ethanol, and 2 tons of water were added to decompose unreacted potassium hydride, and then concentrated under reduced pressure. Purify by column chromatography to obtain the product. Yield: 75% This product is a 1:1 mixture of benzylidene carbon diastereomers (high Rf component m: 9.41~
(44°C, low Rf components m, p, 53-55°C), but there is no need to separate them for subsequent reactions.

参考例3 1−0−ヘキサデシル−2,3−0−ベンジリデン−D
−スレイトール−4−ホスホリルコリンの製造: 1−o−ヘキサデシル−2,3−0−ベンジリデン−D
−スレイトール730+vtJlkエーテル50mに溶
解し、トリエチルアミン660η、β−ブロムエチルホ
スホリルジクロライド1.21を加え、室温で12時間
攪拌する。その後、水4m、)’Jエチルアミン2 m
lを加え2時間加熱還流する。冷却後、水10−を加え
エーテル層を分液し、水層はエーテル50mでさらに3
回抽出し、エーテル層を合わせ無水硫酸ナトIJウムで
乾燥後、溶媒1留去する。
Reference example 3 1-0-hexadecyl-2,3-0-benzylidene-D
-Production of threitol-4-phosphorylcholine: 1-o-hexadecyl-2,3-0-benzylidene-D
-Threitol 730+vtJlk Dissolve in 50 ml of ether, add 660 η of triethylamine and 1.21 ml of β-bromoethylphosphoryl dichloride, and stir at room temperature for 12 hours. Then 4 m of water, )'J ethylamine 2 m
1 and heated under reflux for 2 hours. After cooling, 10 m of water was added to separate the ether layer, and the aqueous layer was further diluted with 50 m of ether for 3
After extraction, the ether layers were combined and dried over anhydrous sodium sulfate, and one portion of the solvent was distilled off.

残渣をメタノール2−に溶解し、トリメチルアミン2−
を加え封管反応容器中55〜60℃で12時間加熱還流
する。冷却後、濃縮し、残渣を90%メタノール水溶液
30−に溶解し、酢酸銀300〜を加え室温で2時間攪
拌する。不溶物を戸別後、減圧濃縮し、残渣をカラムク
ロマトグラフィーで精製して目的物583■を得る。
The residue was dissolved in methanol 2- and trimethylamine 2-
and heated under reflux at 55 to 60°C for 12 hours in a sealed reaction vessel. After cooling, the mixture is concentrated, and the residue is dissolved in 90% aqueous methanol solution (30%), and 300% of silver acetate is added thereto, followed by stirring at room temperature for 2 hours. After removing the insoluble matter, it is concentrated under reduced pressure, and the residue is purified by column chromatography to obtain the desired product 583.

収率 58% m、p、 202〜205℃実施例1 】−0−ヘキサデシル−2,3−ジー0−アセチル−D
−スレイトール−4−ホスホリルコリンの製造: 1−〇−ヘキサデシルー2.3−0−ベンジリデン−D
−スレイトール−4−ホスホリルコリン101 Wを氷
酢酸5−に溶解し、ツヤラジウム黒加キを加えて一気圧
の水素圧下室温で5時間攪拌する。
Yield 58% m, p, 202-205°C Example 1 -0-hexadecyl-2,3-di-0-acetyl-D
-Production of threitol-4-phosphorylcholine: 1-0-hexadecyl-2.3-0-benzylidene-D
-Threitol-4-phosphorylcholine 101W is dissolved in glacial acetic acid 5-, and radium radium is added thereto, followed by stirring at room temperature under one atmosphere of hydrogen pressure for 5 hours.

触媒を戸別後、溶媒を減圧留去する。After discharging the catalyst, the solvent is distilled off under reduced pressure.

残iをクロロホルム5−に溶解し、無水酢酸0.5d、
ピリジン帆5−を加え、加熱還流する。
Dissolve the residue i in chloroform 5-, add 0.5 d of acetic anhydride,
Add pyridine and heat to reflux.

冷却後、クロロホルム10m1+を加え、水10−で2
回水洗し、無水硫酸ナトリウムで乾燥する。溶媒を留去
後、カラムクロマドグ9ラフイーで精製して、白色、ワ
ックス状の目的物86叩を得る。収率86チNMR(I
QQ MB2 0DO1,)0.88 (t 、 3H
)、1.27(s、26H)、 1.4〜1.7 (m
 。
After cooling, add 10ml of chloroform and dilute with 10ml of water.
Wash twice with water and dry with anhydrous sodium sulfate. After distilling off the solvent, the product was purified using column chromatography to obtain white, waxy target product No. 86. Yield 86cm NMR (I
QQ MB2 0DO1,)0.88 (t, 3H
), 1.27 (s, 26H), 1.4~1.7 (m
.

2H)、2.10(8,3H)、 2.11 (Il+
 、 3H)、3.22(S。
2H), 2.10 (8,3H), 2.11 (Il+
, 3H), 3.22 (S.

9H)、 3.25〜3.44(m、 6H)、3.9
2〜4.48(m。
9H), 3.25-3.44 (m, 6H), 3.9
2-4.48 (m.

□H)、 5.12〜5.36 (m 、 2H)特許
出願人 日本曹達株式会社 代理人 伊 藤 晴 之 同 横 山 吉 美
□H), 5.12-5.36 (m, 2H) Patent applicant: Nippon Soda Co., Ltd. Agent Haruno Ito Yoshimi Yokoyama

Claims (2)

【特許請求の範囲】[Claims] (1)一般式 (式中、RはCseまたは01mの直鎖のアルキル基を
示す。)で表わされる化合物。
(1) A compound represented by the general formula (wherein R represents Cse or a straight chain alkyl group of 01m).
(2)一般式 (式中、RはChs または018の直鎖のアルキル基
を示す。)で表わされる化合物を還元し1、次いでアセ
チル化することを特徴とする一般式 (式中、Rは前記と同一の意味を示す。)で表わされる
化合物の製造方法。
(2) A general formula characterized in that a compound represented by the general formula (in the formula, R represents Chs or a linear alkyl group of 018) is reduced 1 and then acetylated (in the formula, R is A method for producing a compound represented by (having the same meaning as above).
JP11252683A 1983-06-22 1983-06-22 Threitol derivative Pending JPS604195A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11252683A JPS604195A (en) 1983-06-22 1983-06-22 Threitol derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11252683A JPS604195A (en) 1983-06-22 1983-06-22 Threitol derivative

Publications (1)

Publication Number Publication Date
JPS604195A true JPS604195A (en) 1985-01-10

Family

ID=14588848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11252683A Pending JPS604195A (en) 1983-06-22 1983-06-22 Threitol derivative

Country Status (1)

Country Link
JP (1) JPS604195A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354383A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Glycerophosphorylcholine derivative
JPS6354382A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Optically active butanetriol derivative
JPS6354381A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Novel butane-1,2,3-triol derivative
JPS63104990A (en) * 1986-10-22 1988-05-10 Teikoku Hormone Mfg Co Ltd Butane-1,2,3,4-tetraol derivative
JPS63104989A (en) * 1986-10-22 1988-05-10 Teikoku Hormone Mfg Co Ltd Alkane-1,2,3-triol derivative

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354383A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Glycerophosphorylcholine derivative
JPS6354382A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Optically active butanetriol derivative
JPS6354381A (en) * 1986-08-26 1988-03-08 Teikoku Hormone Mfg Co Ltd Novel butane-1,2,3-triol derivative
JPS63104990A (en) * 1986-10-22 1988-05-10 Teikoku Hormone Mfg Co Ltd Butane-1,2,3,4-tetraol derivative
JPS63104989A (en) * 1986-10-22 1988-05-10 Teikoku Hormone Mfg Co Ltd Alkane-1,2,3-triol derivative

Similar Documents

Publication Publication Date Title
EP2861554A2 (en) Improved process for the preparation of treprostinil and derivatives thereof
JPS6240348B2 (en)
JPS63280092A (en) Novel beta-d-phenylthioxyloside, manufacture and therapeutical use
JPS604195A (en) Threitol derivative
CN112250546A (en) Synthesis method of (E) -3, 5-dihydroxy-4-isopropyl stilbene
JPS6024781B2 (en) Method for producing cis-2-hydroxy-2-phenyl-r-1-cyclohexanecarboxylic acid
Angyal et al. 978. Cyclitols. Part XVI. Toluene-p-sulphonyl derivatives of myoinositol. Acetyl migration in anhydrous pyridine solution
JPS6344544A (en) Manufacture of dihydrocyclocitral and optically active stereoisomer thereof
McCasland et al. Cyclitols. VI. A New Tetrol and Enediol from Cyclohexadiene-1, 4 by the Prevost Reaction1
US3153067A (en) Substituted octahydroanthracenes
JPH05238990A (en) 1,4,5,8-tetrakis(hydroxymethyl)naphthalene derivative and its production
JP2005220041A (en) Water-soluble transition metal-diamine complex, method for producing the same and use thereof
JPS6053039B2 (en) N-Acetyl/Iramic acid derivative and method for producing the same
CN112390707B (en) Preparation and application of (Z) -3, 5-dihydroxy-4-isopropyl stilbene
JP2776995B2 (en) Process for producing (R)-(+)-dihydro-α-ionone and novel intermediate thereof
JPH0379360B2 (en)
JP2541197B2 (en) Optically active cyclopentene derivative and its production method
JPS62230743A (en) Production of 1-alkoxy-2-methylnaphthalene
CN118146090A (en) Preparation method of propylene glycol dicaprylate or propylene glycol dicaprate
CN117720467A (en) Preparation method of surface chiral [2.2] cycloquinoline imitation catalyst
CN115819307A (en) Preparation method of prostaglandin E1
US2988568A (en) Dibenzo cycloheptadiene carboxylic acid compounds and process of making same
JPS597183A (en) Naphthacenequinone derivative and its preparation
CN118027091A (en) Preparation method of treprostinil and intermediate thereof
CN116969864A (en) Synthesis method of aromatic sulfonyl fluoride compound